identified a subset of CD8+ Tex cells expressing SPRY1, which exhibits a Tpex phenotype and is associated with complete responses to neoadjuvant PD‐1 blockade in esophageal squamous cell carcinoma (ESCC).[104] Notably, Siddiqui et al. Here, SPRY1 is linked to esophageal squamous cell carcinoma.